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Previous studies have shown that early mouse embryos with both FGF-4 alleles inactivated are developmentally arrested
shortly after implantation. To understand the roles of FGF-4 during early development, we prepared genetically engineered
embryonic stem (ES) cells, which are unable to produce FGF-4. Speci®cally, we describe the isolation and characterization
of ES cells with both FGF-4 alleles inactivated. The FGF-40/0 ES cells do not require FGF-4 to proliferate in vitro, and
addition of FGF-4 to the medium has little or no effect on their growth. Thus, FGF-4 does not appear to act as an autocrine
growth factor for cultured ES cells. We also demonstrate that FGF-40/0 ES cells, like their unmodi®ed counterparts, are
capable of forming highly complex tumors in syngeneic mice composed of a wide range of differentiated cells types,
including neural tissue, glandular epithelium, and muscle. In addition, we demonstrate that the FGF-40/0 ES cells can
differentiate in vitro after exposure to retinoic acid; however, the growth and/or survival of the differentiated cells is
severely compromised. Importantly, addition of FGF-4 to the culture medium dramatically increases the number of differen-
tiated cells derived from the FGF-40/0 ES cells, in particular cells with many of the properties of parietal extraembryonic
endoderm. Finally, we demonstrate that there are differences in the RNA pro®les expressed by the differentiated progeny
formed in vitro from FGF-40/0 ES cells and FGF-4/// ES cells when they are cultured with FGF-4. Taken together, the
studies described in this report indicate that certain lineages formed in vitro are affected by the inactivation of the FGF-
4 gene, in particular speci®c cells that form during the initial stage of ES cell differentiation. Thus, ES cells with both
FGF-4 alleles inactivated should shed light on the important roles of FGF-4 during the early stages of mammalian develop-
ment and help determine why FGF-40/0 embryos die shortly after implantation. q 1997 Academic Press
INTRODUCTION FGFs play essential roles in numerous biological processes
during vertebrate development. Studies performed with
dominant-negative FGF receptors provided clear support forThere are at least 14 members of the ®broblast growth
an essential role of FGFs during amphibian developmentfactor (FGF)2 family and at least 4 FGF-receptor genes (re-
(Amaya et al., 1993). In humans, defects in three of the FGF-viewed in Miller and Rizzino, 1994; also see Smallwood et
receptor genes have been linked directly to genetic disordersal., 1996 and Yamasaki et al., 1996). It is now clear that
of bone development (Shiang et al., 1994; Rousseau et al.,
1994; Reardon et al., 1994; Muenke et al., 1994), and gene
targeting studies provide unequivocal proof for the require-1 To whom correspondence should be addressed. Fax: 402-559-
ment of speci®c FGF receptors during mouse development4651. E-mail: ARIZZINO@UNMC.EDU.
(Deng et al., 1994, 1996; Yamaguchi et al., 1994; Colvin et2 Abbreviations used: ES, embryonic stem; EC, embryonal carci-
al., 1996). In addition, gene targeting studies have identi®ednoma; FGF, ®broblast growth factor; ICM, inner cell mass; FBS,
the requirement for several FGFs during mouse develop-fetal bovine serum; LIF, leukemia inhibitory factor; RA, retinoic
acid; tPA, tissue plasminogen activator; Endo B, keratin 18. ment. Inactivation of both alleles of the FGF-3 gene causes
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defects in the development of the inner ear and the tail and 1985; Rizzino et al., 1988; Miller and Rizzino, 1996b). How-
ever, EC cells and ES cells may produce all the FGF-4 thatthese mice often fail to survive to adulthood (Mansour et al.,
1993). Gene targeting studies have also directly implicated they require. Thus, it is unclear whether FGF-4 is an essen-
tial autocrine growth factor for early embryonic cells. In thisFGF-5 and FGF-7 in hair growth and development (HeÂbert
et al., 1994; Guo et al., 1996). Thus far, the most severe report, we have addressed this important issue and several
related questions by employing gene targeting to inactivateeffects have been observed with the inactivation of the FGF-
4 gene (Feldman et al., 1995). both alleles of the FGF-4 gene in ES cells. Speci®cally, the
work described in this report addressed four questions: (1)FGF-4 appears to be the ®rst FGF expressed during mam-
malian development. Its expression has been observed at Can FGF-40/0 ES cells be isolated in culture; (2) do FGF-
40/0 ES cells require or respond to FGF-4 in vitro; (3) canthe RNA level as early as the four-cell stage (Rappolee et
al., 1990). By the blastocyst stage, FGF-4 RNA expression FGF-40/0 ES cells differentiate in culture and do the differen-
tiated cells respond to FGF-4; (4) can FGF-40/0 ES cells formis restricted to the cells of the inner cell mass (ICM) (Nis-
wander and Martin, 1992), which give rise to the three em- tumors in vivo and is the range of cell types in these tumors
different from the tumors derived from their unmodi®edbryonic germ layers. As the embryo undergoes gastrulation,
FGF-4 RNA is restricted to the primitive streak where it counterparts?
continues to be expressed for several additional days. After
organogenesis is initiated, FGF-4 is expressed in many tis-
sues, including the myotome cells of mature somites, the MATERIALS AND METHODS
branchial arches, and the apical ectodermal ridge of the de-
veloping limb. These ®ndings prompted speculation that Growth and Differentiation of ES Cells
FGF-4 plays important roles at multiple stages of develop-
R1 ES cells (Nagy et al., 1993) were provided by A. Nagy and J.ment (Niswander and Martin, 1992). This was con®rmed
Rossant (Mount Sinai Hospital, Toronto, Canada) and D3 ES cellsfor early development by the ®nding that mouse embryos
(Doetschman et al., 1985) were provided by T. Doetschman (Uni-with both FGF-4 alleles inactivated (FGF-40/0) are develop-
versity of Cincinnati, Cincinnati, OH). ES cells were grown in high
mentally arrested shortly after implantation (Feldman et glucose-containing DME medium (Gibco/BRL, Grand Island, NY)
al., 1995). Interestingly, at the blastocyst stage, FGF-40/0 supplemented with 15% fetal bovine serum (FBS; Intergen, Pur-
embryos appear to be morphologically normal. However, chase, NY), 0.1 mM b-mercaptoethanol (Sigma, St. Louis, MO), and
when FGF-40/0 embryos are cultured in vitro, the ICM and 2 ng/ml recombinant human leukemia inhibitory factor (LIF; Pepro
Tech Inc., Rocky Hills, NJ) as described previously (Ma et al., 1992).its derivatives, unlike those from FGF-4/// embryos, degen-
In most cases, ES cells were maintained on a feeder layer of g-erate unless FGF-4 is added to the culture medium (Feldman
irradiated, neomycin-resistant embryonic ®broblasts derived fromet al., 1995).
transgenic mouse embryos (13.5 to 16.5 days of gestation). ES cellsTo understand the developmental defects caused by inac-
grown without a feeder layer were cultured on gelatin-coated ¯askstivation of the FGF-4 gene at a time when the embryo is
in medium supplemented with LIF at a concentration of 10 ng/ml.small in size and not readily observed or manipulated, we
Differentiation of ES cells was induced by addition of 1 mM retinoic
have initiated a study of FGF-4 expression and function acid (RA; Fisher Scienti®c, Pittsburgh, PA) to culture medium con-
using embryonic stem (ES) cells. ES cells, like their tumor- taining 2 ng/ml LIF. ES cells undergoing differentiation were refed
derived counterparts, embryonal carcinoma (EC) cells, pro- with fresh medium every other day. Where indicated, cell numbers
vide a useful model system for studying early mammalian were determined electronically with a Coulter counter after tryp-
sinization. All cells were cultured in a moist atmosphere of air anddevelopment (reviewed in Rizzino, 1993). These cells can
5% CO2 at 377C.be induced to differentiate into cell types derived from the
ICM during mammalian embryogenesis. Equally important,
ES cells and EC cells express FGF-4 at the RNA and protein
Gene Targeting Vectors for Disrupting Bothlevels, whereas after differentiation, in particular into pari-
Alleles of the FGF-4 Geneetal and visceral extraembryonic endoderm-like cells, FGF-
4 expression is repressed (Yoshida et al., 1988; Velcich et Both FGF-4 alleles in R1 ES cells were inactivated with gene
al., 1989; Tiesman and Rizzino, 1989). In addition, several targeting vectors containing isogenic DNA (mouse strain 129) iso-
lated from a genomic l library constructed with DNA from CC1.2studies have shown that ES cells and EC cells express FGF
ES cells. The gene targeting vector used to inactivate the ®rst FGF-receptors at the RNA and protein levels (Rizzino et al., 1988;
4 allele contained a 7.8-kb fragment of the FGF-4 gene (XhoI±SalI),Mummery et al., 1993), and, at least for F9 EC cells, FGF-
derived from a 16-kb genomic clone (BamHI±BamHI). The MluI4 appears to be the primary, if not the only, FGF expressed
site in exon 3 of the FGF-4 gene was converted to a BamHI siteat the protein level (Miller and Rizzino, 1996a). These ®nd-
using BamHI linkers, into which a promoterless LacZ gene (Man-ings and the ®nding that FGF-4 is essential during em-
sour et al., 1990) and a neomycin resistance gene cassette,
bryogenesis have raised the possibility that FGF-4 is an es- MC1neopA (Thomas and Capecchi, 1987), were inserted. This mod-
sential autocrine growth factor for ES cells, EC cells, and i®ed genomic DNA was inserted between the HSV-TK1 and HSV-
the cells of the ICM. Interestingly, addition of FGF-4 to TK2 cassettes (Chisaka and Capecchi, 1991), which had been in-
the culture medium of EC cells and ES cells has not been serted into the vector pSP65 (Promega, Madison, WI).
The vector used to inactivate the remaining FGF-4 allele wasobserved to increase their proliferation (Heath and Rees,
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constructed by replacing the neomycin resistance gene in the vector Westborough, MA) using a turboblotter (Schleicher and Schuell,
Keene, NH) according to manufacturer's instructions. DNA waspSSC (Chauhan and Gottesman, 1992) with the puromycin resis-
tance gene (pPUR, Clontech, Palo Alto, CA) to create pSSC-pur. UV-crosslinked to the membranes with a Stratagene Stratalinker
and the membranes were hybridized using QuikHyb (Stratagene)The next step involved the addition of FGF-4 genomic DNA to
pSSC-pur. On the 3* side of the puromycin resistance gene, a 2.7- with a 32P-labeled BamHI to BglII fragment that is located down-
stream from the targeting construct. Positive clones were then con-kb fragment of the FGF-4 gene was inserted into pSSC-pur between
its BamHI and ClaI sites. The 2.7-kb fragment used in this vector ®rmed by digestion with BsgI and subsequent Southern blot analy-
sis. This analysis identi®ed four FGF-40/0 ES cell clones (FD6, GB3,extended from the BglII site in exon 3 to the BamHI site in the 3*
¯anking region of the gene. On the 5* side of the puromycin resis- HD3, and IC3). DNA from each of the four clones was hybridized
with a puromycin probe and only a single copy of the puromycintance gene cassette, a 4.5-kb fragment from the FGF-4 gene was
inserted. The 4.5-kb fragment extended from the XhoI site in the gene was detected (data not shown).
5* ¯anking region of the FGF-4 gene to the AscI site in intron 1.
Thus, the resulting gene-targeting vector contained the puromycin
Generation of FGF-4//0 Miceresistance gene ¯anked by two regions of the FGF-4 gene such that
the selection marker replaced exon 2 and part of exon 3 of the FGF-
FGF-4//0 ES cells were microinjected into C57BL/6 mouse blas-4 gene.
tocysts to produce chimeric mice, and male chimeras were bred
with C57BL/6 females to produce heterozygous offspring as de-
scribed previously (Mansour et al., 1993). Heterozygous males andElectroporation of ES Cells and Drug Selection females were mated to determine the fate of FGF-40/0 offspring.
Heterozygous offspring were identi®ed by Southern blot analysis ofThe conditions for electroporation and drug selection during the
tail DNA with the BamHI±SpeI 3* ¯anking probe described above.®rst round of gene targeting have been described previously (Man-
Where indicated, embryos (8.5 days of gestation) were genotypedsour et al., 1988; Deng and Capecchi, 1992). To inactivate the sec-
by PCR using yolk sac DNA and three primers based on the se-ond FGF-4 allele, 342 FGF-4//0 ES cells (1±3 1 107) were washed
quence of the FGF-4 gene (Brookes et al., 1989). A primer (5*-AGT-twice in PBS, resuspended in PBS (0.8 ml) containing 20 mg of the
GCTCCTCCTGAGGGGTAG) from the antisense strand of thetargeting vector (linearized with Eco47 III), and electroporated with
FGF-4 gene starting at position 1708 (relative to the transcriptiona Bio-Rad gene pulser (240 V, 500 mF, 0.4 cm cuvette). After electro-
start site) and a primer (5*-TAGCCAGAGCCAGGCTGGGTT)poration, 342 ES cells were plated on six 100-mm gelatin-coated
from the sense strand at position 1193 generate a product of approx-tissue culture dishes in medium supplemented with recombinant
imately 500 bp from the wild-type allele. The primer from theFGF-4 (10-15 ng/ml) (R&D Systems, Inc., Minneapolis, MN). Puro-
antisense strand of the FGF-4 gene and a third primer (5*-TCTATC-mycin (Sigma) was added to the media 18±24 h after electropora-
GCCTTCTTGACGAGTTC) from the neomycin resistance genetion at an initial concentration of 0.1 mg/ml, which was increased
cassette generate a product of approximately 300 bp from the alleleto 0.2 mg/ml on the third day and 0.5 mg/ml on the fourth day after
inactivated by the gene targeting vector described in Fig. 1A.electroporation. During the second day after electroporation, G418
(200 mg/ml, active reagent, Gibco/BRL) and gancyclovir (2 mM, Cy-
tovene, Syntex Laboratories, Palo Alto, CA) were added. The cells
Bioassay for FGF Activitywere refed daily until the majority of the cells died in response to
puromycin, G418, and gancyclovir. Thereafter, the cells were refed A [3H]thymidine incorporation bioassay was used to measure the
every other day. Twelve days after electroporation, selected colo- amount of FGF-4 in media conditioned by ES cells as described
nies were trypsinized and reseeded without drugs in 96-well plates previously (Miller and Rizzino, 1996b). This bioassay employs qui-
on a feeder layer of embryonic ®broblasts. escent NR-6-R1 cells, which are EGF receptorless NIH 3T3 cells
that were selected for a strong response to FGFs (Rizzino and Ruff,
1986). ES-cell-conditioned medium was prepared by replacing the
Screening of Drug-Selected ES Cells by Southern serum-supplemented culture medium of the cells with serum-free
Blot Analysis medium (DME/F12 containing 45 mg/ml heparin to stabilize any
FGF activity). After 15 h, the serum-free conditioned media were
Drug-resistant clones were screened by Southern blot analysis collected, and cell numbers were determined by trypsinizing the
to identify ES cell clones in which the FGF-4 gene had been inacti- cells and counting them electronically with a Coulter counter. The
vated. For this purpose, genomic DNA was isolated from cells se- conditioned media were concentrated approximately 20-fold using
lected during the ®rst round of gene targeting as described pre- Centriprep 10 columns (Amicon) and stored at0807C until assayed.
viously (Condie and Capecchi, 1993). The DNA was digested with
BamHI and probed with a 0.8-kb SpeI±BamHI DNA fragment from
the 3* end of the FGF-4 gene, which was not contained in the Northern Blot Analysis
targeting vector. Southern blot hybridization was performed using
standard protocols (Thomas and Capecchi, 1987). These studies A FastTrack 2.0 kit (Invitrogen, San Diego, CA) was used to
isolate poly(A)/ RNA from nearly con¯uent cultures of FGF-4///determined that 67% of the drug-selected ES cell clones had under-
gone homologous recombination. ES cells, FGF-40/0 ES cells, FGF-4/// differentiated cells untreated
or treated with FGF-4, and FGF-40/0 differentiated cells untreatedDuring the second round of gene targeting, genomic DNA was
prepared from ES cells using a high salt precipitation method or treated with FGF-4. Each mRNA sample (3 mg) was denatured
in 11 Mops running buffer (40 mM Mops, pH 7, 10 mM sodium(Miller et al., 1988). DNA was digested with NsiI (New England
Biolabs, Beverly, MA) and separated on an 0.8% agarose gel. South- acetate, and 1 mM EDTA), 2.2 M formaldehyde, and 50% for-
mamide at 657C for 15 min. The samples were subjected to electro-ern blots were performed using standard protocols. In brief, DNA
was transferred to a nylon membrane (Micron Separations, Inc, phoresis in a 1% agarose gel containing 11 Mops running buffer
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and 0.22 M formaldehyde and transferred to a MSI nylon membrane into the third exon of the FGF-4 gene (Fig. 1A). This cassette,
(Fisher Scienti®c, Pittsburgh, PA) in 101 SSPE (1.5 M NaCl, 0.1 M which disrupts the FGF-4 gene, contains a promoterless
NaH2PO4, and 10 mM EDTA, pH 7.4) that was subsequently UV- LacZ gene and a neomycin resistance gene under the control
crosslinked. The membrane was prehybridized in a solution con- of the MCl promoter. R1 ES cells were electroporated with
taining 51 SSPE, 51 Denhardt's, 50% formamide, 1% SDS, and the gene-targeting vector and subjected to drug selection in
100 mg/ml denatured salmon testis DNA for 2 h at 427C. Hybridiza-
medium containing G418 and gancyclovir using methodstions were performed with 32P-labeled probes in the buffer described
described previously (Mansour et al., 1988; Deng and Capec-above at 427C for 16±18 h. After each hybridization, the membrane
chi, 1992). Southern blot analysis was performed withwas washed as follows: (1) 0.1% SDS±21 SSPE for 10 min at room
BamHI-digested DNA and a 0.8-kb SpeI±BamHI DNAtemperature (repeated once); (2) 0.1% SDS±0.51 SSPE for 15 min
at 507C; (3) 21 SSPE rinse. Finally, the levels of transcripts were probe from the 3* end of the gene, which was not in the
measured by phosphorimage analysis (Molecular Dynamic, Sun- targeting vector. This analysis demonstrated that 67% of
nyvale CA). All probes detected a single band of the predicted tran- the drug-resistant ES cell clones were homologous recombi-
script size. The b-actin fragment, isolated from the plasmid pHFbA- nants (data not shown).
1 (Gunning et al., 1983), was used to con®rm equivalent loading FGF-4//0 ES cells identi®ed by the above screen were used
of samples. The remaining DNA probes were prepared as previously to generate germline chimeric mice by injecting the cells
described (Miller and Rizzino, 1996b).
into C57BL/6 embryos as described under Materials and
Methods. Germline transmission of the inactivated FGF-4
allele was determined by Southern blot analysis of BamHI-
DNA Fragmentation Assay for Apoptosis digested tail DNA using a 0.8-kb SpeI±BamHI DNA probe.
Mice heterozygous for the mutant FGF-4 gene appearedDNA fragmentation was examined in undifferentiated FGF-
completely normal. However, mating of the heterozygous4/// and FGF-40/0 ES cells as well as in their differentiated progeny
mice gave rise only to progeny that contained at least onecultured in the presence and absence of recombinant FGF-4. Both
functional FGF-4 allele (Table 1). This was true for adultadherent cells and culture supernatants for each cell type and cul-
ture condition were collected 48 h after seeding, pelleted by centrif- mice, newborns, and embryos genotyped at 8.5 days of ges-
ugation (3000g), and rinsed twice with phosphate-buffered saline. tation. These results not only con®rmed the reported role
DNA was isolated from the collected cells using a TACS apoptotic of FGF-4 during early development (Feldman et al., 1995),
DNA laddering kit (Trevigen, Inc., Gaithersburg, MD). To enhance but also demonstrated the functional inactivation of the
the sensitivity of the apoptotic laddering assay, 1 mg of cellular targeted FGF-4 allele.
DNA from each experimental condition was radioactively labeled
The next step was to inactivate the remaining FGF-4 al-with [a-32P]dCTP (3000 Ci/mmol) by a Klenow ®ll-in reaction. Ra-
lele. For this purpose, one of the ES cell clones generateddiolabeled DNAs were electrophoresed in a 1.5% agarose gel in 11
during the studies described above (referred to as 342) wasTAE running buffer (40 mM Tris acetate, 2 mM EDTA) for 2 h at
used for a second round of gene targeting. This was accom-100 V. After electrophoresis, the gel was ®xed overnight in 10%
plished with a vector in which exon 2 and part of exon 3 ofacetic acid, dried, and examined by phosphoimage analysis.
the FGF-4 gene were replaced with a puromycin resistance
gene (Fig. 1B). During the second round of gene targeting,
the culture medium was supplemented with FGF-4 (10 ng/Tumor Analysis
ml) in the event that the FGF-40/0 ES cells could not survive
Strain 129/SvJ mice (Jackson Labs) were injected subcutaneously without this growth factor, and the cells were subjected to
in the hind ¯ank with 106 ES cells in 0.1 ml PBS. The tumors that drug selection in medium containing puromycin, G418, and
formed were resected at the times indicated in the legend of Table gancyclovir as described under Materials and Methods. Ini-
3, sized, and ®xed in fresh 10% buffered Formalin overnight. The tially, 120 drug-resistant colonies were picked and screened
following day the tumors were embedded in paraf®n. Four-micro- by Southern blot analysis using an 845-bp BamHI±BglII
meter-thick sections were cut and stained with hematoxylin and
probe from the 3* end of the FGF-4 gene that was not in-eosin.
cluded in the targeting vector (Fig. 1B). Following digestion
of genomic DNA with NsiI, this probe hybridizes to a 7.4-
kb fragment from the wild-type FGF-4 gene (Fig. 1C). In the
342 FGF-4//0 ES cells, the allele with the LacZ-neo insertRESULTS
generates a 13-kb NsiI fragment. In contrast, the puromycin-
based targeting vector introduces a new NsiI restriction siteTargeted Disruption of the FGF-4 Gene
into the gene resulting in a 5.4-kb NsiI fragment. During
the initial screen, four doubly targeted ES cell clones wereThe immediate goal of the work described in this report
is to determine whether FGF-4 produced by ES cells affects identi®ed (FD6, GB3, HD3, and IC3) (Fig. 1C). Correct tar-
geting was con®rmed by digesting the DNA from each oftheir growth and/or their differentiation. Toward these
goals, we sought to create ES cells in which both alleles these clones with BsgI, which produces a 4.9-kb fragment
from the wild-type allele and fragments of 6.1 and 6.4 kbof the FGF-4 gene were inactivated sequentially by gene
targeting. The ®rst allele was inactivated using a gene tar- from the ®rst and second targeted alleles, respectively
(Fig. 1C).geting vector with a selection marker gene cassette inserted
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FIG. 1. Inactivation of the FGF-4 gene by gene targeting. (A) The gene targeting vector used to inactivate the ®rst allele of the FGF-4
gene was constructed with a LacZ-neomycin resistance gene cassette inserted into the third exon (E3) of the FGF-4 gene as described
under Materials and Methods. It should be noted that the MluI site in exon 3 was converted to a BamHI site for the purpose of constructing
the gene targeting vector. Also shown is the structure of the targeted allele after homologous recombination. The positions of the three
exons in the FGF-4 gene are shown in black as E1, E2, and E3. (B) The gene targeting vector used to inactivate the remaining FGF-4 allele
was constructed with a puromycin resistance gene inserted in place of exon 2 and part of exon 3 of the FGF-4 gene as described under
Materials and Methods. The AscI and the BglII sites ¯anking the puromycin gene cassette were destroyed during the construction of the
targeting vector. The XhoI site, although destroyed during construction of the targeting vector, should be present in the targeted allele.
Also shown is the structure of the targeted allele after homologous recombination. The 0.8-kb SpeI±BamHI DNA fragment (not shown),
which was used as a probe after the ®rst round of homologous recombination, is immediately 5* to the BamHI±BglII fragment used as a
probe after the second round of gene targeting. (C) Southern blot analysis was used to demonstrate that both alleles of the FGF-4 gene
were inactivated. The DNA from FGF-40/0 ES cell clones (FD6, GB3, HD3, and IC3), FGF-4//0 ES cells (342/3C-1), and wild-type ES cells
(ES) were digested with NsiI (N) or BsgI (B) and subjected to Southern blot analysis using the BamHI±BglII probe shown in B. Sizes of the
diagnostic fragments are indicated on the right for BsgI and on the left for NsiI.
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FIG. 1ÐContinued
Characterization of the FGF-40/0 ES Cells and FGF-4//0 ES cells destroyed their biological activities.
In contrast, media conditioned by FGF-40/0 ES cell clones,As indicated above, recombinant FGF-4 was added to the
GB3 and FD6, even when added at a 10-fold higher concen-medium to guard against the possibility that the FGF-4 pro-
tration, did not stimulate thymidine incorporation aboveduced by ES cells is an essential autocrine growth factor.
background. Moreover, no inhibitory activity was detectedHowever, as described in the next section, the growth of
in medium conditioned by the FGF-40/0 ES cells when itFGF-40/0 ES cells is not dependent on the addition of recom-
was mixed with medium conditioned by FGF-4/// ES cellsbinant FGF-4 to the culture medium. Hence, we were able
(Fig. 2). Taken together, these ®ndings con®rm that theto culture the cells in medium that was not supplemented
FGF-4 gene has been knocked out, and argue that FGF-with FGF-4. This enabled us to collect medium conditioned
40/0 ES cells do not release other FGF-related mitogenicby FGF-40/0 ES cells and verify with a bioassay that the
growth factors, such as FGF-1 and FGF-2, which are knownFGF-4 gene had been inactivated. For this purpose, we em-
to stimulate thymidine incorporation in the bioassay usedployed a bioassay based on mitogenic stimulation of [3H]-
in this study.thymidine incorporation by quiescent NR-6-R1 mouse ®-
Previous studies with EC cells and ES cells failed to ob-broblasts. These cells are EGF-receptorless NIH 3T3 cells
serve any growth stimulation when FGFs, including FGF-that were selected for enhanced response to FGFs (Rizzino
4, were added to the culture medium (Heath and Rees, 1985;and Ruff, 1986). This bioassay has been used in several other
Rizzino et al., 1988; Miller and Rizzino, 1996b), evenstudies to monitor the production of FGF-4 by EC cells and
though they express receptors for FGFs (Rizzino et al., 1988;ES cells (Rizzino et al., 1988; Tiesman et al., 1988; Miller
Mummery et al., 1993). Although it is possible that theyand Rizzino, 1996a,b). In the current study, conditioned me-
do not require FGF-4 for growth, it is also possible that theydia were collected from nontargeted ES cells (FGF-4///), 342
produce more FGF-4 than is needed for their proliferation.ES cells (FGF-4//0), and two of the gene inactivated ES cell
Hence, we sought to determine whether FGF-4 would affectclones GB3 and FD6 (FGF-40/0). As expected, media condi-
the growth of FGF-40/0 ES cells. Initial observations indi-tioned by FGF-4/// ES cells and 342 ES cells strongly stimu-
cated that each of the FGF-40/0 ES cell clones could prolifer-
lated thymidine incorporation (Fig. 2). As in the case of
ate rapidly without the addition of FGF-4 to the culture
recombinant FGF-4 and FGF-4 produced by EC cells (Riz-
medium. Thus, we examined whether prolonged prolifera-
zino et al., 1988, Tiesman et al., 1988), heat treatment (707C tion of FGF-40/0 ES cells required the addition of recombi-
for 10 min) of conditioned media from FGF-4/// ES cells nant FGF-4 to their culture medium. For this purpose, two
of the gene inactivated ES cell clones, GB3 and FD6, were
cultured on a feeder layer in medium without FGF-4 supple-
mentation for 20 generations (6 passages). During thatTABLE 1
time, the average doubling time for both clones was approxi-Genotype of Offspring Derived from Mating FGF-4//0 Micea
mately 14 hr in either the presence or the absence of FGF-
Age FGF-4/// FGF-4//0 FGF-40/0 4 supplementation (Table 2), which is a typical growth rate
for ES cells. Although the growth-inactivated feeder layer
Adult 80 128 0 secretes little if any FGF activity (data not shown), we con-
Newborn 14 24 0 sidered the possibility that the feeder layer supplies an es-8.5 days of gestation 12 26 0
sential factor, which masked the requirement for FGF-4.
However, when two other FGF-40/0 ES cell clones, HD3 anda The genotype of the offspring was determined as described un-
der Materials and Methods. IC3, were grown without a feeder layer over a period of
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FIG. 2. Production of FGF-4 by gene inactivated ES cells. Media conditioned by FGF-40/0 ES cells (clones FD6 and GB3), FGF-4//0 ES
cells (324-3C1), and wild-type ES cells were tested for the presence of FGF-4 activity by a [3H]thymidine incorporation assay as described
under Materials and Methods. Bars and error bars represent the mean and standard deviation of relative thymidine incorporation (cpm)
from triplicate samples. The amount of thymidine incorporation observed represents the mitogenic activity released by 105 FGF-40/0 ES
cells or the amount of mitogenic activity released by 104 342 ES cells or 104 FGF-4/// ES cells. Abbreviations: HT, heat treated; ES,
conditioned medium prepared from FGF-4/// ES cells; FD6 and GB3, conditioned media prepared from FGF-40/0 ES cell clones.
20 generations (6 passages), their doubling times were 4 for their survival nor respond to it mitogenically. In this
regard, it should be stressed that the serum present in theapproximately 17 h with or without FGF-4 (Table 2). Thus,
all of the evidence argues that ES cells neither require FGF- medium used to culture the ES cells was unlikely to contain
TABLE 2
Effects of FGF-4 on the Doubling Time of FGF-40/0 ES Cellsa
FD6 ES FD6 ES GB3 ES GB3 ES HD3 ES HD3 ES IC3 ES IC3 ES
Passb / / / /
FGF-4 FGF-4 FGF-4 FGF4
3 14.1 12.5 15.3 16.0 18.1 18.1 15.6 17.0
4 13.7 15.2 15.6 14.0 16.8 17.7 15.1 16.8
5 13.9 14.4 13.4 13.5 15.8 18.4 19.3 23.0
6 13.5 12.2 13.1 14.4 15.3 15.3 13.2 13.2
Average 13.8 13.6 14.4 14.5 16.5 17.4 15.8 17.5
SD { 0.3 { 1.5 { 1.3 { 1.1 { 1.2 { 1.4 { 2.5 { 4.0
a FD6 ES and GB3 ES were grown on feeders, but for HD3 and IC3 the feeders were replaced by LIF. Where indicated, FGF-4 was used
at 10 ng/ml.
b Pass, passage number.
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FIG. 3. Morphology of FGF-4/// and FGF-40/0 ES cells. FGF-4/// ES cells (A), FD6 FGF-40/0 ES cells (B) and GB3 FGF-40/0 ES cells (C)
were cultured for several passages without feeder layers on gelatin-coated surfaces in the absence of recombinant FGF-4. As in the case
of FGF-4/// ES cells, FD6 and GB3 ES cells grow as tightly packed colonies, and have minimal cytoplasm and a large nucleus with one
or more prominent nucleoli. Bar scale in C, 35 mm.
FGF activity, since the serum was heat-inactivated (567C with distinct cell borders (Fig. 4A). In direct contrast to the
colonies formed by R1 ES cells, the vast majority (85%)for 30 min) under conditions known to inactivate FGFs,
such as FGF-1, FGF-2, and FGF-4 (Rizzino et al., 1988; Ties- of the colonies formed by FD6 FGF-40/0 ES cells had few if
any associated differentiated cells (Fig. 4B). Equally im-man et al., 1988). Finally, it is noteworthy that FGF-40/0 ES
cells cultured in the absence of recombinant FGF-4 exhibit a portant, addition of FGF-4 during the clonal growth of the
cells led to dramatic increases in the presence of differenti-morphology typical of ES cells whether they were cultured
on a growth-inactivated feeder layer (data not shown) or on ated cells in the FD6 ES cell cultures (Fig. 4C). Interestingly,
the morphology of the differentiated cells formed undergelatin-coated surfaces in the absence of a feeder layer (Fig.
3). Speci®cally, the ES cells grew as tightly packed colonies, these conditions (Figs. 4A and 4C) is similar to that of pari-
etal extraembryonic endoderm. In this experiment, the cellsand have minimal cytoplasm and a large nucleus with one
or more nucleoli. were stained with Coomassie blue prior to photography,
which uniformly stained the densely packed core of ES cells.
These ®ndings make two important points. First, the sur-
vival and/or the proliferation of the differentiated cells atDifferentiation of FGF-40/0 ES Cells
low density is severely compromised by inactivation of the
FGF-4 gene, which leads us to suggest that FGF-4 producedIn view of the fact that FGF-4 is not essential for the
by the ES cells acts as a paracrine growth factor to promotegrowth of ES cells, yet it is essential during early embryonic
the growth of the differentiated cells that form spontane-development, we examined the differentiation of FGF-40/0
ously at low density. However, the possibility remains thatES cells under two different culture conditions: RA-induced
FGF-4 promotes the differentiation of ES cells. Second, con-differentiation and spontaneous differentiation at low cell
sistent with our FGF bioassay (Fig. 2), FGF-40/0 ES cells dodensities. In both cases, the ES cells were plated in the
not appear to produce signi®cant amounts of FGFs that arepresence of LIF without a feeder layer. At low cell density,
functionally related to FGF-4.the cloning ef®ciencies of R1 FGF-4/// ES cells and FD6
FGF-40/0 ES cells were the same, 31% in each case. How- To understand more fully the effects of inactivating the
FGF-4 gene on the differentiation of ES cells, we examinedever, clear-cut differences were noted in the number of dif-
ferentiated cells that formed when the cells were plated at the ability of the ES cells to undergo differentiation when
treated with RA. As in the case of FGF-4/// ES cells, FGF-clonal densities. The vast majority (75%) of clones formed
by R1 ES cells consisted of a central core of ES cells sur- 40/0 ES cells undergo morphological differentiation within
48 h. Moreover, 4 days after the initial exposure to RA, few,rounded by an outer layer of larger, ¯at differentiated cells
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FIG. 4. Morphology of FGF-4/// and FGF-40/0 ES cells grown at clonal density. R1 FGF-4/// ES cells (A), FD6 FGF-40/0 ES cells (B), and
FD6 FGF-40/0 ES cells grown in the presence of FGF-4 (10 ng/ml) (C) were cultured for 8 days without feeder layers on gelatin-coated
surfaces in the presence of LIF (10/ml). Prior to photography, the cells were stained with Coomassie blue. Bar scale in C, 160 mm.
if any, of the cells exhibited the morphology of ES cells (Fig. ment is seriously compromised. Importantly, the same ob-
servations were made with each of the three FGF-40/0 ES5). However, there was a very prominent difference between
cultures derived from FGF-40/0 and FGF-4/// ES cells. In cell clones examined thus far, FD6, GB3, and HD3.
Interestingly, the number of differentiated cells in cul-multiple experiments, we observed far fewer differentiated
cells (sixfold in the experiment shown) in cultures derived tures derived from 342 ES cells (FGF-4//0) was consistently
higher than the number of differentiated cells in the cul-from FGF-40/0 ES cells than in cultures derived from R1 ES
cells (FGF-4///) (Fig. 6). Furthermore, more dead ¯oating tures derived from FGF-40/0 ES cells, yet consistently lower
than the number of differentiated cells observed in culturescells were observed in the RA-treated FGF-40/0 ES cell cul-
tures. Hence, the proliferation and/or the survival of differ- derived from R1 ES cells (Fig. 6). In addition, since FGF-
40/0 ES cells produce no detectable FGF-4 and 342 ES cellsentiated cells derived from FGF-40/0 ES cells after RA treat-
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FIG. 5. Morphology of differentiated cells derived from FGF-4/// and FGF-40/0 ES cells. R1 FGF-4/// ES cells and FD6 FGF-40/0 ES cells
were cultured on gelatin-coated surfaces in medium containing LIF (2 ng/ml) and induced to differentiate with RA (1 mM). R1-differentiated
(A and C) and FD6-differentiated cells (B and D) were cultured grown in the presence (C and D) or absence (A and B) of FGF-4 (10 ng/ml),
and photographed 96 h after the initial exposure to RA. Bar scale in D, 35 mm.
appear to produce less FGF-4 than FGF-4/// ES cells (Fig. The low number of differentiated FGF-40/0 cells and the
increases in cell number induced by FGF-4 were not only2), we examined whether FGF-4 could stimulate the growth
and/or survival of the differentiated cells formed in response observed in multiple paired experiments, such as the one
shown in Figs. 6 and 7, but these observations were also madeto RA. Addition of recombinant FGF-4 dramatically in-
creased the number of differentiated cells in cultures de- when we compared the number of differentiated cells derived
from FGF-40/0 ES cells to the number of differentiated cellsrived from the three FGF-40/0 ES cell clones and greatly
reduced the differential observed between the cells derived derived from another FGF-4/// ES cell line, D3 (data not
shown). Again, many more differentiated cells were observedfrom FGF-4/// ES cells, FGF-4//0 ES cells and FGF-40/0 ES
cells (Fig. 7). Although FGF-4 induced a small increase in cultures derived from D3 ES cells than in cultures derived
from either GB3 or FD6 FGF-40/0 ES cells. Furthermore, the(50%) in the number of differentiated cells derived from R1
ES cells, FGF-4 typically increased the number of differenti- difference in the number of differentiated cells was reduced
dramatically by addition of FGF-4 to the culture media ofated cells in the cultures derived from FGF-40/0 ES cells
more than 400%. In these experiments, FGF-4 was used at FGF-40/0 cells. Thus, it appears that FGF-4 produced by FGF-
4/// ES cells acts as a paracrine growth factor to promote the5 ng/ml. However, a single addition of FGF-4 (20 ng/ml) at
the start of the experiment when RA was added to the cul- growth and/or survival of their differentiated cells.
tures was nearly as effective. Increases of more than 2.5-
fold were also observed when a single dose of FGF-4 (5 ng/
Properties of the Differentiated Cellsml) was added to the FGF-40/0-differentiated cells 2 days
after the addition of RA (data not shown). Furthermore, To examine further the possibility that FGF-4 serves as
an important paracrine growth factor for the differentiatedsmall increases in cell number were observed with FGF-4
at concentrations as low as 100 pg/ml (data not shown). cells derived from ES cells in vitro, we initiated studies to
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isolated from R1 (FGF-4///) ES cells and FD6 (FGF-40/0) ES
cells, and their differentiated progeny, which formed after
a 96-h exposure to RA. Transcripts for Endo B and tPA were
upregulated signi®cantly when R1 ES and FD6 ES cells were
treated with RA (Fig. 8; compare lanes 1 and 2, or lanes 4
and 5, respectively), indicating that both FGF-4/// and FGF-
40/0 cells had undergone differentiation. However, no lami-
nin B1 and only low levels of type IV collagen transcripts
were observed in the absence of exogenously added FGF-4.
When FGF-4 was added to the culture medium, signi®cant
differences were revealed between the populations of differ-
entiated cells derived from FGF-4/// and FGF-40/0 ES cells.
Speci®cally, laminin B1 transcripts were observed and tran-
scripts for type IV collagen were elevated, but only for differ-
entiated FGF-40/0 cells (Fig. 8, lane 6). This enhancement
FIG. 6. Growth of differentiated cells derived from FGF-40/0 ES
cells, FGF-4//0 ES cells and FGF-4/// ES cells. ES cells (50,000 per
35 mm well) were induced to differentiate with 1 mM RA at the
start of the experiment (time zero) as described under Materials
and Methods. After 2 days, the cells were refed with fresh medium
containing RA. Cell numbers were determined daily with a Coulter
counter. The values shown represent the mean number of cells in
triplicate wells. Standard deviations were less than 11% of the
mean except for one case (25% for FD6 on day 4). This experiment
was repeated in whole or in part more than six times.
address three questions: to what extent are the FGF-40/0
cells able to commence the program of differentiation, are
there differences in the properties of the differentiated cells
derived from FGF-4/// ES cells and FGF-40/0 ES cells, and
are the properties of the differentiated cells in¯uenced by
the addition of FGF-4 to the culture medium? As part of
this analysis, we sought to determine whether RA induced FIG. 7. Growth of differentiated cells derived from FGF-40/0 ES
cells, FGF-4//0 ES cells, and FGF-4/// ES cells in medium supple-the ES cells to form cells that exhibit the properties of pari-
mented with FGF-4. ES cells (50,000 per 35 mm well) were inducedetal extraembryonic endoderm, which is one of the ®rst cell
to differentiate with 1 mM RA at the start of the experiment (timetypes to form during early mammalian development and
zero) in medium supplemented with FGF-4 (5 ng/ml) as describedwhich have been shown to be growth-stimulated by FGFs
under Materials and Methods. The cells were refed with fresh me-(Rizzino et al., 1988; Rappolee et al., 1994). For this purpose,
dium after 2 days and FGF-4 (5 ng/ml) was added daily. Cell num-Northern blot analysis was used to probe for the presence
bers were determined daily with a Coulter counter. The values
of transcripts for four genes that are expressed by parietal shown represent the mean number of cells in triplicate wells. Stan-
extraembryonic endoderm: type IV collagen, keratin 18 dard deviations were less than 11% of the mean. This experiment
(Endo B), tissue plasminogen activator (tPA), and the B1 was repeated in whole or in part more than six times. The data
chain of laminin (Adamson and Ayers, 1979; Singer et al., presented here are derived from an experiment performed in parallel
with the experiment shown in Fig. 6.1986; Marotti et al., 1982; Hogan, 1980). Poly(A)/ RNA was
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pected, since FGF-4 increases the number of differentiated
cells, especially in the cultures of the differentiated cells
derived from FGF-40/0 ES cells (Figs. 5 and 7). Thus, al-
though differentiation of ES cells appears to be accompanied
by an increase in cell death, no differences were observed
in the amount of DNA fragmentation exhibited by the FGF-
4///- and the FGF-40/0-differentiated cells, nor did FGF-4
appear to suppress DNA fragmentation in either population
of differentiated cells. Nonetheless, it should be borne in
mind that apoptosis does not always culminate in the cleav-
age of DNA into internucleosomally sized fragments (Ucker
et al., 1992). However, during a 4-day period, the addition
of Z-VAD (0.2±20 mM), a general caspase inhibitor, which
inhibits apoptosis, did not increase the number of differenti-
ated cells in cultures of FD6 ES cells undergoing differentia-
tion in response to RA (data not shown). Based on these
FIG. 8. Northern blot analysis of RNA expressed by FD6 FGF-
40/0 ES cells, R1 FGF-4/// ES cells and their differentiated progeny.
The growth and differentiation of the cells is described in the text.
Approximately 3 mg of mRNA was loaded into each lane: FGF-
4/// ES cells (lane 1), FGF-4/// differentiated cells (lane 2), FGF-
4/// differentiated cells treated with FGF-4 (lane 3), FGF-40/0 ES
cells (lane 4), FGF-40/0 differentiated cells (lane 5), FGF-40/0 differ-
entiated cells treated with FGF-4 (lane 6). Transcript sizes for coll
IV (collagen IV), LamB1 (laminin B1), tPA (tissue plasminogen acti-
vator), EndoB (keratin 18), and b-actin are indicated to the right of
the blot. Where used, FGF-4 was added at the time of plating at 20
ng/ml.
in the markers associated with parietal extraembryonic en-
doderm observed for FD6-differentiated cells treated with
FGF-4 is consistent with their growth response to FGF-4,
as well as with previous observations that FGFs stimulate
the growth of parietal endoderm-like cells.
As noted earlier, there are more ¯oating, dead cells in the
cultures of differentiated cells derived from FGF-40/0 ES
cells than in the cultures of differentiated cells derived from
their FGF-4/// counterparts. Previous studies have demon-
strated that retinoic acid can induce both differentiation
and apoptosis in F9 EC cells (Atencia et al., 1994). Hence,
we sought to determine whether the increased cell death
upon differentiation of FGF-40/0 ES cells was due to
apoptosis. In most instances, cells undergoing apoptosis ex-
hibit cleavage of DNA into internucleosomally sized frag-
ments. Therefore, we employed a DNA laddering assay to FIG. 9. DNA laddering in both undifferentiated and differentiated
FGF-4/// and FGF-40/0 ES cells. ES cells (250,000 per 100-mm dish)examine whether differentiation of FGF-40/0 ES cells in-
and RA-induced (1 mM) ES-differentiated cells (500,000 per 100 mmcreases the amount of DNA fragmentation in the cultures.
dish) were grown as described under Materials and Methods. WhereBoth wild-type and mutant ES cells exhibited approxi-
indicated, FGF-4 (20 ng/ml) was added to the culture medium whenmately the same amount of DNA laddering (Fig. 9), and no
the cells were plated. DNA was isolated 48 h later, radiolabeled,increases were observed 24 h after the addition of RA (data
and analyzed as described under Materials and Methods. Equivalentnot shown). However, the level of DNA laddering increased
gel-loading was con®rmed by ethidium bromide staining (upper
signi®cantly, and to the same extent, when FGF-4/// and panel) after a short period of electrophoresis. DNA laddering is
FGF-40/0 ES cells were treated with RA for 48 h (Fig. 9). shown in the lower panel. Lanes: 1, FGF-4/// ES cells; 2, FGF-
Surprisingly, FGF-4 did not alter the amount of DNA lad- 4///-differentiated cells; 3, FGF-4///-differentiated cells cultured
dering in the differentiated cells derived from either wild- with FGF-4; 4, FGF-40/0 ES cells; 5, FGF-40/0-differentiated cells;
6, FGF-40/0-differentiated cells cultured with FGF-4.type or FGF-40/0 ES cells (Fig. 9). This result was not ex-
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TABLE 3
Histopathology of Tumors Formed by FGF-4/// ES Cells, FGF-//0 ES Cells, and FGF-40/0 ES Cellsa
R1 342 FD6 GB3 GB3h
(///) (//0) (0/0) (0/0) (0/0)
Tissue type (3/3) (4/5) (2/5) (2/4) (2/2)
Embryonic stem cells /00 00// 00 00 /0
Primitive neuroectoderm //0 00/0 /0 00 //
Mature neural tissue /// //// // // //
Skeletal muscle /// //// // // //
Glandular epithelium /// //// // // //
Squamous epithelium //0 0/// // 0/ /0
Cartilage //0 00// 00 00 /0
Bone 0/0 00/0 00 00 /0
a 61 days after the mice were injected with 106 ES cells, the tumors were resected, ®xed in 10% buffered Formalin, and processed for
histopathological analysis as described under Materials and Methods. However, two of the R1 tumors were removed at 30 and 47 days
after injection. In addition, one of the 342 tumors and one of the FD6 tumors were removed 35 days after injection. The genotypes of
R1 ES cells and 342 ES cells are FGF-4/// (///) and FGF-4//0 (//0), respectively. The genotype of FD6 ES cells and GB3 ES cells is FGF-
40/0 (0/0). The passage numbers (after the second round of gene targeting) of the FD6 and GB3 ES cells at the time of injection were both
14. The passage number of GB3h ES cells at the time of injection was 40. The incidence of tumor formation for each ES cell clone is
indicated by the numbers presented within parentheses. The presence of a speci®c tissue type, but not its amount, is indicated by a /.
If the tissue type was not observed in the sections examined, it was scored as a 0. Most of the glandular tissue consisted of cystic spaces
lined by cuboidal or columnar epithelium with variable differentiation into ciliated and mucous cells.
®ndings, the enhanced cell death observed in the population inactivation of one or both alleles of the FGF-4 gene does
not ablate the ability of the ES cells to form tumors. None-of FD6-differentiated cells may occur by a nonapoptotic
theless, it is possible that differences exist in the incidencepathway.
of tumor formation or the rate at which the tumors grow
when FGF-40/0 ES cells are employed. Resolving this issue
will require a much larger study. Since other experimentalTumorigenicity of FGF-40/0 ES Cells
approaches, which focus on the initial stages of ES cell dif-
To determine whether inactivation of the FGF-4 gene in- ferentiation, are likely to be more informative regarding the
¯uences the differentiation of ES cells into cells that form essential role of FGF-4 during early development, this issue
later in development, we examined the ability of FGF-4///, was not pursued in the current study.
FGF-4//0, and FGF-40/0 ES cells to form teratocarcinomas To address whether inactivation of the FGF-4 gene alters
(tumors composed of a wide range of differentiated cell the ability of ES cells to form a wide range of differentiated
types derived either directly or in multiple steps from ES cell types, the histopathology of the tumors was examined.
cells). In this study, two questions were addressed. First, do We determined that ES cells with one or both alleles inacti-
ES cells with one or both inactivated FGF-4 alleles retain vated retained the capacity to differentiate into many differ-
the potential to form tumors in syngeneic mice? Second, ent cell types, including cells derived from each of the three
does inactivation of the FGF-4 gene alter the ability of the embryonic germ layers (Table 3). Interestingly, one of the
cells to undergo differentiation or to form a wide range of tumors derived from GB3 ES cells (FGF-40/0), like one of the
differentiated cell types? For these studies, strain 129/SvJ tumors derived from R1 ES cells and 342 ES cells, exhibited
mice were used because R1 ES cells were derived from limited differentiation. However, this GB3 tumor was the
mouse strain 129. Each ES cell genotype formed tumors smallest tumor observed in the study. In contrast, another
when injected subcutaneously into the hind ¯ank of the tumor derived from this ES cell clone, which was produced
mice. In the case of the R1 ES cells, tumors formed in each from higher passage GB3 ES cells, formed the largest tumor
of the three mice injected. In the case of the 342 ES cells, in the study and this tumor exhibited a full panel of differen-
tumors formed in 4 of 5 mice injected, and, in the cases of tiated cells types. Thus, it appears that inactivation of the
the FD6 and GB3 ES cells, tumors formed in 6 of the 11 FGF-4 gene does not prevent FGF-40/0 ES cells from differ-
mice injected (Table 3). We also observed that the sizes of entiating into many of the cell types that typically form
the tumors varied between the different ES cell clones, with during the development of teratocarcinomas. Nonetheless,
R1 ES cells and 342 ES cells generally forming larger tumors it is possible that the frequency at which certain differenti-
than those formed by FD6 and GB3 ES cells. However, the ated cell types form (e.g., cartilage) is in¯uenced by inactiva-
largest tumor observed in this study was derived from GB3 tion of the FGF-4 gene. This possibility can only be ad-
dressed by a much larger study.ES cells. Taken together, these ®ndings demonstrate that
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bone) do not form in vitro during the initial stages of ESDISCUSSION
cell differentiation.
It is evident that there are substantial differences in theThe ®ndings reported in this study lead to several im-
portant conclusions. ES cells with both FGF-4 alleles inacti- properties of the differentiated FGF-40/0 and FGF-4/// cells
formed in response to RA in vitro. One signi®cant differencevated can be isolated and characterized. FGF-40/0 ES cells
do not require FGF-4 to proliferate nor do they exhibit a is the limited growth of the FGF-40/0-differentiated cells 2
days after the ES cells were induced to differentiate (Fig. 6),signi®cant growth response to FGF-4 in vitro. In addition,
FGF-40/0 ES cells, like their normal counterparts, are tumor- unless FGF-4 was added to the medium (Fig. 7). Another
difference is the higher number of dead cells in the culturesigenic and they can give rise to tumors composed of a wide
range of differentiated cells. However, as discussed below, derived from FGF-40/0 ES cells, especially 2 days after the
addition of RA. These observations suggest that the survivalthere are signi®cant differences in the properties of the dif-
ferentiated cells that form in vitro when FGF-40/0 ES cells of the RA-induced FGF-40/0-differentiated cells is signi®-
cantly lower, and this reduced cell survival is likely to beare treated with RA or when they are plated at clonal densi-
ties. Moreover, our studies, in particular those performed related to the virtual absence of differentiated cells in the
stock cultures of FGF-40/0 ES cells and the low number ofat clonal cell densities, suggest that FGF-4 produced by ES
cells can act as a paracrine growth factor for their differenti- differentiated cells in cultures of FGF-40/0 ES cells plated
at clonal densities (Fig. 4).ated progeny.
Early studies led to the suggestion that FGF-4 might be Another signi®cant difference between the differentiated
cells formed by FGF-40/0 ES cells and FGF-4/// ES cells isan autocrine growth factor for ES cells and EC cells. This
argument grew out of the ®nding that these cells both pro- the markers that they express. Although both populations
of differentiated cells expressed type IV collagen, Endo B,duce FGF-4 and express several FGF-receptor genes. In addi-
tion, the FGF receptors expressed by EC cells have been and tPA, only the FGF-40/0-differentiated cells expressed
transcripts for the B1 chain of laminin and only when FGF-shown to be functional (Miller et al., 1993). Nonetheless,
addition of various FGFs to the medium of EC and ES cells 4 was added to the media. In addition, the expression of
transcripts for type IV collagen was greater in cultures offailed to promote their growth under a variety of conditions,
including when FGFs were added to serum-containing me- FGF-40/0-differentiated cells cultured with FGF-4. Although
detailed studies will be needed to fully understand thisdium, serum-free medium or at low cell densities where it
is more dif®cult for cells to condition their culture medium ®nding, it appears that there are differences in the cell types
present in the populations of differentiated cells derived(Heath and Rees, 1985; Rizzino et al., 1988; Miller and Riz-
zino, 1996b). Consequently, either ES cells and EC cells do from FGF-40/0 ES cells and FGF-4/// ES cells.
It is unclear why the populations of differentiated cellsnot require FGF-4 or they produce all the FGF-4 required
for their proliferation (Rizzino, 1993). The studies described derived from FGF-40/0 ES cells and FGF-4/// ES cells appear
to be different. One possibility is that the FGF-4 producedin this report de®nitively resolve this question for ES cells
by demonstrating that FGF-40/0 ES cells do not require FGF- by FGF-4/// ES cells in¯uences the process of differentia-
tion, which leads to the formation of different cell types. An4 to proliferate nor do they respond mitogenically to FGF-
4 when it is added to their culture medium during short- equally plausible explanation is that the same differentiated
cells form initially in the cultures derived from FGF-40/0term or long-term growth studies.
FGF-4 is known to be expressed at several points during ES cells and FGF-4/// ES cells, but there is selective loss of
speci®c differentiated cell types in the cultures derived frommammalian development (Niswander and Martin, 1992). In
addition to its expression during embryogenesis, where FGF-40/0 ES cells. Currently, we cannot distinguish be-
tween these alternatives and it is possible that both contrib-FGF-4 is essential, FGF-4 is expressed by several other tis-
sues, including in the developing limb where it is thought ute to the cell types that comprise the population of the
differentiated cells 4 days after the addition of RA.to play important roles (Laufer et al., 1994; Haramis et al.,
1995; Duprez et al., 1996). In view of the possible impor- The full signi®cance of the differences between the popu-
lation of differentiated cells derived from FGF-40/0 ES cellstance of FGF-4 later in development, we examined the abil-
ity of FGF-40/0 ES cells to form tumors in syngeneic mice. and the population derived from FGF-4/// ES cells remains
to be determined. However, the close relationship betweenOur studies suggest that the potential for FGF-40/0 ES cells
to form a wide range of cell types in vivo is similar to that ES cells and the totipotent cells of the ICM at the blastocyst
stage leads us to suggest several hypotheses. In this regard,of FGF-4/// ES cells. In this regard, the same range of tissues
was observed in tumors derived from both FGF-40/0 ES cells the embryonic lethality observed with FGF-40/0 embryos in
vivo and the degeneration of FGF-40/0 blastocysts culturedand FGF-4/// ES cells. Nonetheless, as discussed below, im-
portant differences were observed between FGF-40/0 ES in vitro does not appear to be due to the direct dependence
of the totipotent cells of the ICM on FGF-4, since FGF-4cells and FGF-4/// ES cells when they were induced to dif-
ferentiate in vitro. The reason why dramatic differences does not appear to be an autocrine growth factor for ES cells.
Instead, our ®ndings suggest that the degeneration of FGF-were observed in vitro but not in vivo is likely to be due to
the cell types formed. The cell types that are identi®ed 40/0 embryos is due to the absence of FGF-4, which is likely
to serve as an essential paracrine growth factor for the sur-readily in teratocarcinomas (e.g., muscle, cartilage, and
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nitz, D. M., and Leder, P. (1994). Murine FGFR-1 is required forvival and/or proliferation of differentiated cells derived from
early postimplantation growth and axial organization. Genesthe ICM. This possibility is consistent with the ®nding that
Dev. 8, 3045±3057.FGF-4 added to mouse blastocysts developing in vitro in-
Deng, C. X., Wynshaw-Boris, A., Zhou, F., Kuo, A., and Leder, P.creases the number of parietal extraembryonic endoderm
(1996). Fibroblast growth factor receptor 3 is a negative regulatorcells derived from the ICM (Rappolee et al., 1994). Given
of bone growth. Cell 84, 911±921.
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